Lans Holdings Inc (fka LAHO)

[ApollyonZ]

$LAHO Stem cells is the future of medicine. FDA will lose enormous funds and is voicing the concern like a cartel out right denying science, reason and logic.

Death by Prescription

FDA says it’s unable to use the incomplete adverse event reporting data to quantify overall deaths that result from therapeutic drug use.

https://health.usnews.com/health-news/patient-advice/articles/2016-09-27/the-danger-in-taking-prescribed-medications

Scientists Are Developing New Ways to Treat Disease With Cells, Not Drugs

https://www.cancerresearch.org/blog/december-2018/james-allison-nobel-postdoc-fellow-perspectives

..“There has been an increased demand to develop effective drugs for cardiology and degenerative disorders, for which there were no effective treatment plans before the advent of stem therapies

https://www.dailyprogress.com/opinion/opinion-commentary-global-stem-cell-therapy-market-to-showcase-growth/article_aeabbd8e-0106-11e7-a193-db25ffa753ac.amp.html

Harvard Stem Cell

..Our mission is to find cures for human disease

https://hsci.harvard.edu/





Regenerative medicine will dramatically alter the U.S. healthcare industry

.Because of the economic potential of this industry (the worldwide market for regenerative medicine is conservatively estimated to be $500 billion..

$LAHO



An example of some conditions and diseases that could be easily cured by regenerative medicine and their current cost of treatment include:

250,000 patients receive heart valves, at a cost of $27 billion annually
950,000 people die of heart disease or stroke, at a cost of $351 billion annually(8)
17 million patients with diabetes, at a cost of $132 billion annually

..By doing so, we can make tissue and organ failure a relic of the past by 2020.

Interagency Federal Working Group on Regenerative Medicine

Chair
Howard Zucker, MD, JD
Deputy Assistant Secretary for Health
U.S. Department of Health and Human Services

National Institutes of Health
Donna Dean, PhD
Colleen Guay-Broder, MPH
Eleni Kousvelari, PhD
Christine Kelley, PhD
John Watson, PhD
Josh Zimmerberg, PhD

Food and Drug Administration
Charles Durfor, PhD
Donald Fink, PhD
Joyce Frey, PhD
Jesse Goodman, MD
Darin Weber, PhD
Celia Witten, PhD

http://singularity-2045.org/HHS-regenerative-medicine-2020-vision-archive-2014.html

This is real personalized medicine, which is the "Holy Grail." Cells were taken from a patient and used to create the treatment.

https://stansberryresearch.com/articles/the-most-expensive-tech-stock-in-the-world-today-2

Oxford University

..a revolution in biology has meant that effective regenerative medicine, using stem cells to replace and repair damaged tissue is now on the horizon.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=150088612

Blood stem cells produced in vast quantities in the lab

..“The finding is very unexpected and exciting,” says John Dick, a stem-cell biologist at the Prince Margaret Cancer Centre in Toronto, Canada.

If the technique can be applied to humans, it could be used to grow blood stem cells for use in people with blood cancers such as leukaemia whose immune systems have been damaged by chemotherapy.

https://www.nature.com/articles/d41586-019-01690-w

..Cell therapy, as defined by the FDA, is ‘The prevention, treatment, cure or mitigation of disease or injuries in humans by the administration of autologous (derived from same cells), allogeneic or xenogeneic cells that have been manipulated or altered ex vivo’ (1). In autologous stem cell administration, cells are derived from the donor and applied to the donor, while allogeneic stem cell administration involves the transfer of cells from healthy donors to afflicted recipients.

https://www.ddw-online.com/therapeutics/p217261-large-scale-expansion-of-stem-cells-for-therapy-and-screening.html

Researchers Discover Stem Cells Responsible for Growing and Healing Bone

https://news.weill.cornell.edu/news/2018/10/researchers-discover-stem-cells-responsible-for-growing-and-healing-bone

Stanford researchers develop a gel for growing large quantities of neural stem cells

A new gel could help grow the large quantities of neural stem cells needed for sought-after therapies. Its success depends on the cells’ ability to stay in touch.

https://news.stanford.edu/2017/11/02/gel-helps-grow-large-quantities-stem-cells-limited-space/

Exosomes are currently non-reactive and FDA approved.

https://www.abc-7.com/story/40368805/adimarket-releases-new-exosomes-product-that-delivers-therapeutic-promise

$LAHO